AP2008004400A0 - Inhibitors of HIV integrase enzyme - Google Patents

Inhibitors of HIV integrase enzyme

Info

Publication number
AP2008004400A0
AP2008004400A0 AP2008004400A AP2008004400A AP2008004400A0 AP 2008004400 A0 AP2008004400 A0 AP 2008004400A0 AP 2008004400 A AP2008004400 A AP 2008004400A AP 2008004400 A AP2008004400 A AP 2008004400A AP 2008004400 A0 AP2008004400 A0 AP 2008004400A0
Authority
AP
ARIPO
Prior art keywords
inhibitors
hiv integrase
integrase enzyme
enzyme
hiv
Prior art date
Application number
AP2008004400A
Other languages
English (en)
Inventor
Klaus Ruprecht Dress
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37684843&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AP2008004400(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of AP2008004400A0 publication Critical patent/AP2008004400A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AP2008004400A 2005-10-07 2006-09-25 Inhibitors of HIV integrase enzyme AP2008004400A0 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US72448405P 2005-10-07 2005-10-07
US73070105P 2005-10-26 2005-10-26
US76160506P 2006-01-24 2006-01-24
US82395406P 2006-08-30 2006-08-30
US82637906P 2006-09-20 2006-09-20
PCT/IB2006/002735 WO2007042883A1 (en) 2005-10-07 2006-09-25 Inhibitors of the hiv integrase enzyme

Publications (1)

Publication Number Publication Date
AP2008004400A0 true AP2008004400A0 (en) 2008-04-30

Family

ID=37684843

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2008004400A AP2008004400A0 (en) 2005-10-07 2006-09-25 Inhibitors of HIV integrase enzyme

Country Status (21)

Country Link
US (1) US20070099915A1 (de)
EP (1) EP1934220A1 (de)
JP (1) JP2009511463A (de)
KR (1) KR20080042171A (de)
AP (1) AP2008004400A0 (de)
AR (1) AR061398A1 (de)
AU (1) AU2006300926A1 (de)
BR (1) BRPI0616657A2 (de)
CA (1) CA2623506A1 (de)
CR (1) CR9859A (de)
EA (1) EA200800758A1 (de)
IL (1) IL189939A0 (de)
MA (1) MA29855B1 (de)
NL (1) NL2000255A1 (de)
NO (1) NO20081230L (de)
PE (1) PE20070494A1 (de)
RS (1) RS20080141A (de)
SV (1) SV2009002864A (de)
TW (1) TW200800219A (de)
UY (1) UY29843A1 (de)
WO (1) WO2007042883A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0510306A (pt) * 2004-04-26 2007-09-04 Pfizer inibidores da enzima de hiv integrase,composição farmacêutica contendo os referidos inibidores bem como seu uso
US20110015158A1 (en) 2007-12-11 2011-01-20 Viamet Pharmaceuticals, Inc. Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties
CN102532021B (zh) * 2012-01-31 2013-10-16 天津大学 2-烷氧基-3,4-二取代异喹啉-1(2h)-酮类衍生物的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ194747A (en) * 1979-08-29 1988-11-29 Schering Ag 9h-pyrido(3,4-b)indol-3-ylcarboxylic acid derivatives
AU2409992A (en) * 1991-08-08 1993-03-02 Tsumura & Co. Carcinostatic compound and production thereof
EP0713877A1 (de) * 1993-07-19 1996-05-29 LUO, Xuande Qinghaosuderivate zur bekämpfung von aids
US6057297A (en) * 1996-08-06 2000-05-02 Polifarma S.P.A. Inhibitor compounds of zinc-dependent metalloproteinases associated with pathological conditions, and therapeutic use thereof
FR2754262B1 (fr) * 1996-10-08 1998-10-30 Synthelabo Derives de 1h-pyrido[3,4-b]indole-4-carboxamide, leur preparation et leur application en therapeutique
US6403347B1 (en) * 1998-02-03 2002-06-11 Merck & Co., Inc. HIV integrase inhibitors
AU8009900A (en) * 1999-10-13 2001-04-23 Merck & Co., Inc. Hiv integrase inhibitors
AU6989501A (en) * 2000-06-16 2001-12-24 Bristol Myers Squibb Co Hiv integrase inhibitors
PA8586801A1 (es) * 2002-10-31 2005-02-04 Pfizer Inhibidores de hiv-integrasa, composiciones farmaceuticas y metodos para su uso
MXPA05007563A (es) * 2003-01-27 2005-09-21 Pfizer Inhibidores de la integrasa del vih, composiciones farmaceuticas y metodos para su uso.
BRPI0510306A (pt) * 2004-04-26 2007-09-04 Pfizer inibidores da enzima de hiv integrase,composição farmacêutica contendo os referidos inibidores bem como seu uso
EP1802619A1 (de) * 2004-09-07 2007-07-04 Pfizer, Inc. Inhibitoren des hiv-integrase-enzyms

Also Published As

Publication number Publication date
EA200800758A1 (ru) 2008-08-29
CR9859A (es) 2008-06-20
AR061398A1 (es) 2008-08-27
CA2623506A1 (en) 2007-04-19
KR20080042171A (ko) 2008-05-14
NO20081230L (no) 2008-04-08
NL2000255A1 (nl) 2007-04-11
RS20080141A (en) 2009-07-15
SV2009002864A (es) 2009-02-19
UY29843A1 (es) 2007-05-31
AU2006300926A1 (en) 2007-04-19
PE20070494A1 (es) 2007-06-13
IL189939A0 (en) 2008-08-07
BRPI0616657A2 (pt) 2011-06-28
JP2009511463A (ja) 2009-03-19
TW200800219A (en) 2008-01-01
US20070099915A1 (en) 2007-05-03
EP1934220A1 (de) 2008-06-25
MA29855B1 (fr) 2008-10-03
WO2007042883A1 (en) 2007-04-19

Similar Documents

Publication Publication Date Title
PL1948666T3 (pl) Inhibitory integrazy HIV
ME02012B (me) INHIBITORI El AKTIVIRAJUĆIH ENZIMA
EP1881825A4 (de) Hiv-integrasehemmer
EP1725535A4 (de) Hiv-integrasehemmer
EP1756069A4 (de) Hiv-integrasehemmer
IL177189A0 (en) Hiv integrase inhibitors
IL177858A0 (en) Hiv integrase inhibitors
EP1725102A4 (de) Hiv-integrasehemmer
ZA200704130B (en) Protassium salt of an HIV integrase inhibitor
IL232786A0 (en) Inhibitors of e1 enzyme activators
AP2702A (en) Methods for improving the pharmacokinetics of HIV integrase inhibitors
ZA200802585B (en) Pyridopyrimidinone inhibitors of Pl3Kα
IL190292A0 (en) PYRIDOPYRIMIDINONE INHIBITORS OF P13Ka
EP1756114A4 (de) Hiv-integrasehemmer
IL184303A0 (en) Amino-pyridines as inhibitors of ??-secretase
EP1910363A4 (de) Hiv-integrasehemmer
TWI365876B (en) Prodrugs of hiv protease inhibitors
EP1758585A4 (de) Hiv-integrasehemmer
IL183850A0 (en) Hiv protease inhibitors
EP1855672A4 (de) Hiv-proteasehemmer
AP2008004400A0 (en) Inhibitors of HIV integrase enzyme
EP1910356A4 (de) Hiv-integrasehemmer
ZA200706305B (en) HIV protease inhibitors
EP1910355A4 (de) Hiv-integrasehemmer
EP1909578A4 (de) Hiv-integrasehemmer